Psoriasis group urges FDA not to slow drug approvals as response to COX-2 NSAIDs controversy

Psoriasis advocacy group, speaking at FDA hearing, urges FDA not to slow drug approvals as response to COX-2 NSAIDs controversy - (Kensington, MD, February 17, 2005) "Psoriasis Cure Now," a nonprofit patient advocacy group, today urged a joint hearing of two Food and Drug Administration Advisory Committees to tread carefully as it prepares ...

Continue to Psoriasis group urges FDA not to slow drug approvals as response to COX-2 NSAIDs controversy on Medical News Today.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz